High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up

MLA

Kazushige Hayakawa, et al. “High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiotherapy Combined with Long-Term Hormonal Therapy for High-Risk and Very High-Risk Prostate Cancer: Outcomes after 5-Year Follow-Up.” Journal of Radiation Research, vol. 55, Nov. 2013, pp. 509–17. EBSCOhost, https://doi.org/10.1093/jrr/rrt128.

APA

Kazushige Hayakawa, Shouko Komori, Hiromichi Ishiyama, Masaomi Ikeda, Ken-ichi Tabata, Masashi Kitano, Akane Sekiguchi, Takefumi Satoh, Masatsugu Iwamura, Itaru Soda, Shogo Kawakami, Shinji Kurosaka, & Masaki Kimura. (2013). High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up. Journal of Radiation Research, 55, 509–517. https://doi.org/10.1093/jrr/rrt128

Chicago

Kazushige Hayakawa, Shouko Komori, Hiromichi Ishiyama, Masaomi Ikeda, Ken-ichi Tabata, Masashi Kitano, Akane Sekiguchi, et al. 2013. “High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiotherapy Combined with Long-Term Hormonal Therapy for High-Risk and Very High-Risk Prostate Cancer: Outcomes after 5-Year Follow-Up.” Journal of Radiation Research 55 (November): 509–17. doi:10.1093/jrr/rrt128.